Yann Dean

Summary

Publications

  1. doi request reprint Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases
    Yann Dean
    NovImmune SA, Plan les Ouates, Switzerland
    Swiss Med Wkly 142:w13711. 2012
  2. doi request reprint Characterization of a surrogate murine antibody to model anti-human CD3 therapies
    Fabien Dépis
    NovImmune SA, Plan les Ouates, Switzerland
    MAbs 5:555-64. 2013
  3. doi request reprint Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments
    Fabien Dépis
    NovImmune SA, Plan les Ouates, Switzerland
    Arthritis Rheum 64:3189-98. 2012
  4. ncbi request reprint Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1
    Irene Dunn-Siegrist
    NovImmune SA, 1228 Plan les Ouates, Switzerland
    J Biol Chem 282:34817-27. 2007

Collaborators

  • Jerome Pugin
  • Fabien Dépis
  • Marie Kosco-Vilbois
  • Walter Reith
  • Eric Hatterer
  • Bruno Daubeuf
  • Irene Dunn-Siegrist
  • Romain Ballet
  • Sophie Glatt
  • Laura Cons
  • Jean Marc Waldburger
  • Cem Gabay
  • Celine Lamacchia
  • Greg Elson
  • Olivier Leger
  • Yves Poitevin
  • Suzanne Herren

Detail Information

Publications4

  1. doi request reprint Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases
    Yann Dean
    NovImmune SA, Plan les Ouates, Switzerland
    Swiss Med Wkly 142:w13711. 2012
    ..In this review we present a review of preclinical studies evaluating combination therapies using anti-CD3 antibodies for the treatment of autoimmune diseases...
  2. doi request reprint Characterization of a surrogate murine antibody to model anti-human CD3 therapies
    Fabien Dépis
    NovImmune SA, Plan les Ouates, Switzerland
    MAbs 5:555-64. 2013
    ....
  3. doi request reprint Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments
    Fabien Dépis
    NovImmune SA, Plan les Ouates, Switzerland
    Arthritis Rheum 64:3189-98. 2012
    ..The aim of this study was to examine the efficacy of combined therapy with anti-CD3 and anti-TNF in experimental RA...
  4. ncbi request reprint Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1
    Irene Dunn-Siegrist
    NovImmune SA, 1228 Plan les Ouates, Switzerland
    J Biol Chem 282:34817-27. 2007
    ....